[Federal Register Volume 86, Number 39 (Tuesday, March 2, 2021)]
[Notices]
[Pages 12194-12195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04299]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA-L Conflict SEP.
    Date: March 25, 2021
    Time: 11:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Preethy Nayar, Ph.D. Scientific Review Officer 
Scientific Review Branch National Institute on Drug Abuse, NIH 301 
North Stonestreet Avenue Bethesda, MD 20892, 301-443-4577, 
<a href="/cdn-cgi/l/email-protection#2c424d554d5e5c1e6c4f5f5e02424544024b435a"><span class="__cf_email__" data-cfemail="751b140c14070547351606075b1b1c1d5b121a03">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Implementing the HIV Service Cascade for Justice-
Involved Populations (U01--Clinical Trial Optional).
    Date: March 30, 2021.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue Bethesda, MD 20892, (Virtual 
Meeting).

    Contact Person: Sheila Pirooznia, Ph.D.; Scientific Review 
Officer, Division of Extramural Review, Scientific Review Branch, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue 
Bethesda, MD 20892, (301) 496-9350 <a href="/cdn-cgi/l/email-protection#ed9e858884818cc39d849f82829783848cad838485c38a829b"><span class="__cf_email__" data-cfemail="f88b909d919499d688918a979782969199b8969190d69f978e">[email protected]</span></a>.


[[Page 12195]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: February 24, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04299 Filed 3-1-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>